Horizant

Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
GlaxoSmithKline and XenoPort Respond to FDA on Horizant™ for RLS
Yahoo/BusinessWire
Sat, 11/6/10 - 12:57 pm
GSK
XenoPort
Horizant
restless legs syndrome
Update on Xenoport's Horizant
Yahoo/Zacks.com
Thu, 05/27/10 - 06:24 pm
Horizant
XenoPort
Seven Biotech Drugs to Watch in the Second Quarter
BNET Pharma
Tue, 04/13/10 - 10:35 am
Acorda Therapeutics
AMPYRA
Cell Therapeutics
pixantrone
Pixuvri
Dendreon
Provenge
InterMune
Esbriet
Pozen
Vimovo
XenoPort
Horizant
Astellas
OSI Pharmaceuticals
Ironwood
XenoPort Narrows Focus, Cuts Jobs
Forbes
Mon, 03/8/10 - 04:25 pm
XenoPort
layoffs
restructuring
Horizant
The FDA Fires a Warning Shot at Disease-Mongering Drug Companies -- Maybe
BNET Pharma
Wed, 02/24/10 - 05:26 pm
FDA
XenoPort
restless legs syndrome
Horizant
Glaxo, XenoPort face additional FDA questions
Yahoo/AP
Thu, 02/18/10 - 09:26 am
FDA
GSK
XenoPort
Horizant
restless legs syndrome

Pages